International Stem Cell Corp. (OTCMKTS:ISCO – Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.15 and traded as high as $0.1663. International Stem Cell shares last traded at $0.1663, with a volume of 400 shares trading hands.
International Stem Cell Trading Down 2.2%
The stock has a market cap of $1.33 million, a P/E ratio of -8.32 and a beta of 0.18. The stock’s 50-day moving average is $0.14 and its 200-day moving average is $0.15.
International Stem Cell Company Profile
International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.
In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.
Featured Stories
- Five stocks we like better than International Stem Cell
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
